Paper Details

  1. Home
  2. Paper Details

Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.

Author: GrahChristian, MatthesBurkhard, MatthesHarald, MerkleAntje, SchadFriedemann, SteeleMegan L, ThronickeAnja

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study aims to evaluate the effect of Viscum album L. (VA) extract in addition to chemotherapy on survival in stage IV non-small cell lung cancer (NSCLC) patients.
Paper Details　
Original Abstract of the Article :
Stage IV non-small cell lung cancer (NSCLC) is associated with a five-year survival rate of around 1%. Treatment with Viscum album L. (VA) extracts has been shown to reduce chemotherapy (CTx)-related adverse events, decrease CTx dose reductions and improve quality of life in a number of cancers. Rec...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110500/

データ提供：米国国立医学図書館（NLM）

Viscum Album L.: A Potential Ally in the Fight Against Lung Cancer

Stage IV non-small cell lung cancer (NSCLC), a formidable adversary in the fight against [cancer], often presents a challenging clinical scenario. This study explores the potential benefits of Viscum album L., a plant extract, when used in conjunction with chemotherapy for treating Stage IV NSCLC. The research investigates whether Viscum album L. can improve survival outcomes and quality of life in these patients.

A Natural Ally: Viscum Album L. Offers a New Perspective

The study suggests that Viscum album L. may enhance survival outcomes in Stage IV NSCLC patients when combined with chemotherapy. It's like finding a valuable ally in a challenging battle. The study's findings warrant further investigation to understand the mechanisms of action and the long-term benefits of Viscum album L. in treating NSCLC.

A Holistic Approach: Harnessing the Power of Nature in Cancer Treatment

This research underscores the importance of exploring alternative and complementary therapies alongside conventional cancer treatments. It emphasizes the potential of natural remedies, like Viscum album L., to enhance overall well-being and potentially improve survival outcomes.

Dr.Camel's Conclusion

This study offers a promising glimpse into the potential of Viscum album L. as a natural ally in the fight against lung cancer. The research encourages further investigation into the therapeutic benefits and potential mechanisms of action of this plant extract.

Date :
  1. Date Completed 2019-02-14
  2. Date Revised 2022-08-16
Further Info :

Pubmed ID

30148853

DOI: Digital Object Identifier

PMC6110500

Related Literature

Article Analysis
・Effective treatment of european mistletoe
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.